Table 4.
LRC | RFS | OS | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
1 year (%) | 5 years (%) | p-value | 1 year (%) | 5 years (%) |
p-value | 1 year (%) |
5 years (%) |
p-value | ||
Standard pathology | 0.48 | 0.015 | 0.015 | |||||||
pCR | 100 | 92 | 100 | 92 | 100 | 100 | ||||
PR | 100 | 88 | 98 | 63 | 100 | 71 | ||||
NR | 94 | 84 | 86 | 43 | 100 | 65 | ||||
Chevallier | ||||||||||
1 (pCR) | 100 | 86 | 0.96 | 100 | 86 | 0.06 | 100 | 100 | 0.005 | |
2 | 100 | 91 | 100 | 91 | 100 | 100 | ||||
3 | 100 | 90 | 97 | 58 | 100 | 70 | ||||
4 | 100 | N/A | 89 | N/A | 100 | N/A | ||||
Modified-RECIST | ||||||||||
5 (pCR) | 100 | 94 | 0.45 | 100 | 94 | 0.003 | 100 | 100 | 0.011 | |
3 + 4 | 100 | 87 | 98 | 60 | 100 | 71 | ||||
1 + 2 | 93 | 86 | 87 | 40 | 100 | 57 |
Abbreviations: LRC locoregional control rate, NR no response, OS overall survival, pCR pathologic complete response, PR partial response, RECIST Response Evaluation Criteria in Solid Tumors, RFS recurrence-free survival